Anabolic steroid use and ischaemic stroke in a young fitness enthusiast

BMJ Case Rep. 2021 Feb 4;14(2):e234241. doi: 10.1136/bcr-2020-234241.

Abstract

We report a case of ischaemic stroke in a 34-year-old male recreational bodybuilder following a 3-month period of anabolic androgenic steroid (AAS) use and 1-month period of 'post-cycle therapy' (tamoxifen and clomiphene citrate), the latter treatments aimed at restoring normal endogenous testosterone production after initial AAS use. We hypothesise a transient drug-related prothrombotic state with paradoxical embolisation via an atrial septal defect which was later found on bubble echocardiogram. We highlight a rare but important cause of stroke in younger patients which is relevant given the increasing use of AAS misuse among casual fitness enthusiasts. We explore the various possible mechanisms by which AAS use can increase ischaemic stroke risk in such patients.

Keywords: cardiovascular system; drug misuse (including addiction); drugs in sport / doping control; stroke; unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Anticholesteremic Agents / therapeutic use
  • Aspirin / therapeutic use
  • Atorvastatin / therapeutic use
  • Brain Ischemia / chemically induced*
  • Brain Ischemia / diagnostic imaging*
  • Brain Ischemia / drug therapy
  • Clomiphene / administration & dosage
  • Clomiphene / adverse effects
  • Doping in Sports*
  • Echocardiography
  • Estrogen Antagonists / administration & dosage
  • Estrogen Antagonists / adverse effects
  • Exercise / physiology*
  • Heart Septal Defects, Atrial / surgery
  • Humans
  • Ischemic Stroke / chemically induced*
  • Ischemic Stroke / diagnostic imaging*
  • Ischemic Stroke / drug therapy
  • Male
  • Tamoxifen / administration & dosage
  • Tamoxifen / adverse effects
  • Testosterone Congeners / adverse effects*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticholesteremic Agents
  • Estrogen Antagonists
  • Testosterone Congeners
  • Tamoxifen
  • Clomiphene
  • Atorvastatin
  • Aspirin